Open AccessThe age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who receive curative resection followed by adjuvant chemotherapy
Author(s) -
Toru Aoyama,
Naoto Yamamoto,
Mako Kamiya,
Masaaki Murakawa,
Hiroshi Takahashi,
Sho Sawazaki,
Masakatsu Numata,
Satoshi Kobayashi,
Makoto Ueno,
Manabu Morimoto,
Manabu Shiozawa,
Norio Yukawa,
Takashi Oshima,
Takaki Yoshikawa,
Yasushi Rino,
Munetaka Masuda,
Soichiro Morinaga
Publication year - 2020
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_440_18
Subject(s) - medicine , charlson comorbidity index , pancreatic cancer , adjuvant , adjuvant chemotherapy , chemotherapy , surgery , multivariate analysis , cancer , risk factor , gastroenterology , comorbidity , breast cancer
We investigated the impact of the age-adjusted Charlson comorbidity index (ACCI) on the pancreatic cancer survival and recurrence after curative surgery followed by adjuvant chemotherapy.